Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Recruiting

Phase 2

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery EmbolizationPhase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Sponsor:

H. Lee Moffitt Cancer Center and Research Institute

Code:

NCT04879940

Conditions

Prostate Carcinoma

Benign Prostatic Hyperplasia

Eligibility Criteria

Sex: Male

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Merit Medical Embospheres

Radiation Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-25. This information was provided to ClinicalTrials.gov by H. Lee Moffitt Cancer Center and Research Institute on 2025-01-09.